Varonis (VRNS) CFO & COO Guy Melamed receives 125,359 restricted stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Varonis Systems executive Guy Melamed, the company’s CFO and COO, received an equity grant of 125,359 restricted stock units on February 6, 2026. The RSUs carry no purchase price and represent the right to receive an equal number of Varonis common shares as they vest.
The award will vest in four equal annual installments on the last calendar day of February, beginning on February 26, 2027. Following this grant, Melamed directly beneficially owns 608,662 shares of Varonis common stock, aligning his compensation further with shareholder outcomes.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Melamed Guy
Role
CFO and COO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.001 per share | 125,359 | $0.00 | -- |
Holdings After Transaction:
Common Stock, par value $0.001 per share — 608,662 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did VRNS CFO and COO Guy Melamed report?
Guy Melamed reported receiving 125,359 restricted stock units in Varonis Systems common stock. The award is a stock-based compensation grant at no purchase price, increasing his direct beneficial ownership and further tying his pay to Varonis share performance over time.
When do Guy Melamed’s new Varonis (VRNS) RSUs vest?
The 125,359 restricted stock units vest in four equal annual installments. Vesting occurs on the last calendar day of February each year, starting on February 26, 2027, gradually delivering Varonis common shares to Melamed as long as vesting conditions are met.
What type of security was reported in this Varonis (VRNS) Form 4 filing?
The filing reports common stock of Varonis Systems with a par value of $0.001 per share, tied to a grant of restricted stock units. These RSUs entitle Melamed to receive an equal number of common shares upon vesting, without any cash exercise price.
Was there a purchase price for Guy Melamed’s Varonis (VRNS) RSU grant?
The reported transaction price per share is $0. This indicates the 125,359 restricted stock units were granted as part of compensation rather than purchased in the open market, a common structure for executive equity incentives at publicly traded companies like Varonis.
Who is the insider in this Varonis (VRNS) Form 4 and what is his role?
The insider is Guy Melamed, who serves as Chief Financial Officer and Chief Operating Officer of Varonis Systems. His dual role in finance and operations makes his equity holdings and incentives particularly relevant for understanding executive alignment with company performance.